The Current and Potential Role of Pediatric Clinical Pharmacologists in Italy: A Review with Evidence Synthesis and

Anna Parzianello1, Marina Steyde1, Giuliana Decorti1

  • 1Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.

PubMed

Insights

Pediatric clinical pharmacologists are crucial for optimizing drug therapy in children due to their unique physiology. This study highlights their role in multidisciplinary teams, focusing on drug monitoring and safety in pediatric care.

Area of Science:

  • Pediatric Pharmacology
  • Clinical Pharmacy
  • Evidence-Based Medicine

Background:

  • Infants and young children possess unique physiological and developmental characteristics impacting drug pharmacokinetics and pharmacodynamics.
  • Pediatric drug therapy requires specialized knowledge distinct from adult or general patient care.
  • Multidisciplinary teams benefit from dedicated pediatric pharmacology specialists to enhance patient outcomes.

Purpose of the Study:

  • To delineate the role of pediatric clinical pharmacologists within the Italian pediatric clinical care framework.
  • To analyze the existing literature on pediatric pharmacology practices and contributions.
  • To provide insights into the current state of pediatric pharmacologist involvement in clinical settings.

Main Methods:

  • A systematic literature review adhering to PRISMA guidelines was performed.
  • PubMed database searches were conducted for articles published between January 2017 and March 2022.
  • The R package 'revtools' was utilized for title-based article screening and analysis.

Main Results:

  • A total of 1544 articles were initially identified, with 93 ultimately selected for analysis.
  • The selected literature predominantly focused on therapeutic drug monitoring and pharmacovigilance, including adverse drug reactions.
  • Key areas of pediatric clinical pharmacology practice were identified through the reviewed articles.

Conclusions:

  • The study offers an overview of multidisciplinary collaboration in preventing, diagnosing, and treating pediatric diseases.
  • Effective monitoring of pediatric treatments is facilitated by specialized pharmacological input.
  • The integration and long-term strengthening of pediatric clinical pharmacology within healthcare systems are recommended.
Abstract

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.0K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
8.7K
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.9K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
396
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.9K